BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20478303)

  • 1. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
    Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
    Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
    Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
    Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice.
    Cho AS; Jeon SM; Kim MJ; Yeo J; Seo KI; Choi MS; Lee MK
    Food Chem Toxicol; 2010 Mar; 48(3):937-43. PubMed ID: 20064576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic lipid and carbohydrate metabolism in rats fed a commercial mixture of conjugated linoleic acids (Clarinol G-80).
    Giudetti AM; Beynen AC; Lemmens AG; Gnoni GV; Geelen MJ
    Eur J Nutr; 2005 Feb; 44(1):33-9. PubMed ID: 15309462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
    Chen HC; Farese RV
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice.
    Yazdi M; Ahnmark A; William-Olsson L; Snaith M; Turner N; Osla F; Wedin M; Asztély AK; Elmgren A; Bohlooly-Y M; Schreyer S; Lindén D
    Biochem Biophys Res Commun; 2008 May; 369(4):1065-70. PubMed ID: 18339309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
    Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
    Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DGAT inhibitors for obesity.
    Matsuda D; Tomoda H
    Curr Opin Investig Drugs; 2007 Oct; 8(10):836-41. PubMed ID: 17907060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
    Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
    J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
    Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
    King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
    J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse.
    Roy S; Hyogo H; Yadav SK; Wu MK; Jelicks LA; Locker JD; Frank PG; Lisanti MP; Silver DL; Cohen DE
    Hepatology; 2005 Apr; 41(4):887-95. PubMed ID: 15793852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice.
    Lee J; Chae K; Ha J; Park BY; Lee HS; Jeong S; Kim MY; Yoon M
    J Ethnopharmacol; 2008 Jan; 115(2):263-70. PubMed ID: 18023310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver.
    Xing X; Li D; Chen D; Zhou L; Chonan R; Yamahara J; Wang J; Li Y
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):207-15. PubMed ID: 25123789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.
    Velkoska E; Warner FJ; Cole TJ; Smith I; Morris MJ
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):49-55. PubMed ID: 19361967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice.
    Harada K; Shen WJ; Patel S; Natu V; Wang J; Osuga J; Ishibashi S; Kraemer FB
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1182-95. PubMed ID: 12954598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J-Lep(ob/ob) mice.
    Kim HJ; Lee KT; Park YB; Jeon SM; Choi MS
    Mol Nutr Food Res; 2008 Aug; 52(8):965-73. PubMed ID: 18481331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.